Show menu

News

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
image
The digitalisation of the maintenance function to better serve our customers
Read more
image
The Regulatory Affairs Team at Seqens: its strategic status for the Group and its customers
Read more
image
Analysis of hand sanitizers: SEQENS Bourgoin-Jallieu’s Quality Control Laboratory relies on Infra-Red technology
Read more
image
Press kit : Safety is at the heart of our activities
Read more
image
New collaboration between SEQENS and RONDOL
Read more
image
SEQENS and Rondol Group: a new collaboration in formulation research
Read more
image
Flow Chemistry: an innovation to secure the Electronics supply-chain
Read more
image
Faced with the pandemic, the mobilization of the Seqens group’s quality and regulatory teams is essential
Read more
image
Risk management: the human factor
Read more
image
Continuous training to strengthen the quality culture
Read more
image
Seqens introduces mobility in its maintenance and inventory management processes
Read more
image
High performance enzyme ready for shipment
Read more
1 3 4 5 6 7